fluorobenzenes has been researched along with Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, QJ; Ge, JB; Gong, H; Hu, K; Li, H; Qiu, ZH; Sun, AJ; Wu, CN; Zhang, WB; Zhao, G; Zou, YZ | 1 |
| Brown, L; Hoey, A; Levick, S; Loch, D | 1 |
2 other study(ies) available for fluorobenzenes and Hypertrophy
| Article | Year |
|---|---|
The therapeutic effect of rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats.
Topics: Animals; Apoptosis; bcl-Associated Death Protein; Caspase 3; Fibrosis; Fluorobenzenes; Forkhead Transcription Factors; Hypertension; Hypertrophy; Male; Microtubule-Associated Proteins; Myocytes, Cardiac; Nerve Tissue Proteins; Protein Kinase C; Protein Kinase C beta; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Survivin; Ventricular Remodeling | 2012 |
Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.
Topics: Animals; Aorta; Blood Pressure; Desoxycorticosterone; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy; Male; Myocardium; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sodium Chloride, Dietary; Sulfonamides; Ventricular Remodeling | 2006 |